Attached files
| file | filename |
|---|---|
| EX-99.1 - MEDIFAST INC | v171832_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) January 20, 2010
MEDIFAST,
INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-23016
|
13-3714405
|
||
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
||
|
of
incorporation or organization)
|
Ident.
No.)
|
|
11445 Cronhill Drive, Owing Mills,
Maryland
|
21117
|
|
|
(Address of principal executive
offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code (410)-581-8042
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Item
7.01
|
Regulation
FD Disclosure
|
Medifast,
Inc. (NYSE: MED), announced on January 20, 2010 that The Direct Selling
Association (DSA), a national trade association representing more than 200
direct selling companies doing business in the United States, recently
reaffirmed Medifast as a member in good standing that continues to uphold the
requirements of the Association’s Code of Ethics by employing sound business
practices. The release is in response to allegations made against the Company on
the Internet by an unrelated third party.
A copy of Medifast’s press release is
attached hereto as Exhibit 99.1 and hereby incorporated by
reference.
|
Item
9.01
|
Exhibits
|
Exhibits
pursuant to Item 7.01
|
99.1
|
Press
release issued by Medifast, Inc. on January 20,
2010
|
2
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
MEDIFAST,
INC.
|
||
|
Dated:
January 22, 2010
|
||
|
/s/
Michael S. McDevitt
|
||
|
Michael
S. McDevitt
|
||
|
Chief
Executive Officer
|
3